Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
Cameco stock has delivered a very large 5 year return, yet the current checks suggest investors are now paying a premium. Both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples point in the same direction, which raises questions about how much optimism is already in the price.
Cameco has returned roughly 7x over the past 5 years, which puts the recent valuation signals under closer scrutiny.
Recent upgrades tied to a stronger uranium demand story and the planned Westinghouse IPO can support higher expectations, but any disappointment in long term contract activity or nuclear build out could weigh heavily on what investors are willing to pay.
Cameco scores 1 out of 6 on the broader valuation checks, which leans expensive rather than a clear bargain on most measures.
The issue now is whether Cameco’s current price already reflects the bullish uranium backdrop, or if there is still room before valuation becomes a constraint on future returns.
Find out why Cameco’s 27.2% return over the last year is lagging behind its peers.
Is Cameco Getting Expensive on Cash Flow?
The Discounted Cash Flow (DCF) model used here estimates what Cameco’s future cash flows could be worth in today’s money. Cameco generated roughly CA$649.5 million in free cash flow over the last twelve months, and the DCF applies a two stage Free Cash Flow to Equity approach that assumes free cash flow grows for a period and then stabilizes rather than declining.
Based on these assumptions, the model estimates an intrinsic value of about CA$120.50 per share. This is below the current share price, which implies a premium of roughly 12.7% and suggests that the stock screens as overvalued on this cash flow basis. UBS’s recent upgrade, tied to a stronger uranium bull case, may help explain why investors appear willing to pay above what the current DCF indicates is supported by projected cash generation.
On this DCF cash flow analysis, Cameco stock currently appears overvalued relative to its estimated intrinsic value.
Our Discounted Cash Flow (DCF) analysis suggests Cameco may be overvalued by 12.7%. Discover 14 high quality undervalued stocks or create your own screener to find better value opportunities.
CCO Discounted Cash Flow as at Aug 2026
Is Cameco Getting Expensive on Sales?
Story Continues
P/S is a useful cross check for Cameco because revenue tends to be less volatile than earnings for a capital intensive company tied to commodity prices.
Cameco currently trades on a P/S ratio of about 17.0x. That is far above the Oil and Gas industry average of roughly 3.0x and also sits well above the peer group average of about 11.4x. The tailored fair P/S ratio from the model is just 2.3x. The model is heavily penalising the stock on this framework, which makes that number more of a warning flag than a precise target. However, it still highlights how aggressively the shares are priced against their sales base.
Taken together with the DCF work, this rich P/S multiple indicates that investors are already paying up for Cameco’s uranium and nuclear exposure and that there may be limited room for disappointment on future revenue delivery.
On the P/S multiple, Cameco stock currently screens as clearly overvalued relative to both industry norms and the model’s fair ratio.
TSX:CCO P/S Ratio as at Aug 2026
See what the numbers say about this price — find out in our valuation breakdown.
The Cameco Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives for Cameco are designed to connect the valuation puzzle above to concrete expectations for the future. They spell out which paths for Cameco’s growth, margins and earnings would need to play out for the stock to be worth meaningfully more or less than the current price, and they sit within the company’s Community page. Where a single ratio or model throws off one number, Narratives set out the future that number relies on so you can watch whether it is still playing out.
One of the top community narratives on Cameco: 24% undervalued
“Momentum in utility contracting is building, but current volumes are subdued. As uncovered utility uranium needs through 2045 accumulate, the eventual surge in term contracting is expected to drive material price and volume upside…”
Read one of the top narratives on Cameco
Do you think there’s more to the story for Cameco? Head over to our Community to see what others are saying!
The Bottom Line
Cameco looks expensive on both the Discounted Cash Flow (DCF) intrinsic value estimate and the stretched sales multiple, and the broader valuation checks are weak rather than supportive. That combination suggests expectations are already very high and leaves less room for setbacks in uranium pricing, contracting, or project execution. The key question from here is whether Cameco can deliver the revenue and cash flow profile that keeps investors comfortable paying this kind of premium, or whether the current optimism eventually cools and the multiples reset.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CCO.TO.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com